课题基金 / 基金详情

IMPC: Use of IMPC knockout mice and novel transgenic murine models to identify molecular pathways controlling thymic regulatory T cell development

IMPC: Use of IMPC knockout mice and novel transgenic murine models to identify molecular pathways controlling thymic regulatory T cell development
IMPC:使用 IMPC 敲除小鼠和新型转基因小鼠模型来识别控制胸腺调节性 T 细胞发育的分子途径
批准号:
MR/P026117/1
负责人:
William Jenkinson
金额:
$5.09万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

William Jenkinson的其他基金

相似基金

相关文献

中文摘要
翻译
免疫系统对细菌和病毒感染提供了重要的保护作用,另外在防止肿瘤形成方面起着关键的监视作用。参与这一过程的关键免疫细胞类型是T细胞。然而,T细胞不仅在保护性免疫中发挥关键作用,而且如果调节不当,可能会攻击人体自身组织并导致自身免疫性疾病。胸腺是位于胸部上部的器官,是t细胞发育的主要解剖部位。在T细胞发育过程中,T细胞被筛选,以确定它们对我们自身组织产生免疫反应的潜力。那些极有可能攻击人体器官的t细胞被迫经历细胞死亡。然而,这一过程并非100%有效,这意味着有可能引起自身免疫性疾病的t细胞能够在胸腺内逃脱删除。为了控制自身反应性t细胞,胸腺还支持一种高度特化的t细胞的发育,称为调节性t细胞(也称为Treg)。调节性t细胞具有独特的抑制其他t细胞活性的能力,包括自身反应性t细胞。此外,在清除感染后,调节性t细胞也会减少保护性t细胞的反应,如果不加以控制,也可能对旁观者组织造成“友军伤害”。因此,胸腺内产生的调节性t细胞在控制免疫系统活动中起着关键作用,从而影响自身免疫性疾病。然而,控制调节性t细胞发育和功能的确切机制仍然不完全清楚。该项目旨在使用新的实验方法来识别控制胸腺内产生的调节性T细胞的发育和功能的新分子。我们的目标是使用创新的方法,使我们能够准确地识别胸腺内正在发育的调节性T细胞,并在个体定义基因表达缺陷时,量化它们从胸腺向外周循环的输出。控制调节性T细胞发育和功能的新分子的鉴定可能最终为未来治疗性操纵调节性T细胞的方法提供信息,从而调节健康和疾病中的免疫系统活性。
英文摘要
The immune system provides an essential protective role against bacterial and viral infection, and additionally plays a key surveillance role in guarding against tumour formation. A critical immune cell type involved in this process is the T cell. However, T cells not only play a critical role in protective immunity, but if incorrectly regulated can potentially attack the body's own tissues and cause autoimmune disease. The thymus is an organ located within the upper chest that provides the main anatomical site for T-cell development. During T cell development, T-cells are screened for their potential to mount an immune response against our own tissues. Those T-cells bearing a high likelihood of attacking the body's organs are forced to undergo cell death. However, this process is not 100% efficient, meaning that T-cells with the potential to cause autoimmune disease are able to escape deletion within the thymus. In order to keep autoreactive T-cells in check, the thymus additionally supports the development of a highly specialised type of T-cell, termed regulatory T-cells (also called Treg). Regulatory T-cells possess a unique capacity to supress the activity of other T-cells, including autoreactive T-cells. In addition, regulatory T-cells also curtail protective T-cell responses following the clearance of infections, which if left unchecked may also cause 'friendly-fire' damage to bystander tissues. Regulatory T-cells generated within the thymus therefore play a critical role in controlling the activity of the immune system and therefore impact autoimmune disease. However, the precise mechanisms that control regulatory T-cell development and function remain incompletely understood. This project aims to use novel experimental approaches to identify new molecules that control the development and function of regulatory T cells generated within the thymus. We aim to use innovative methods that will allow us to accurately identify regulatory T cells undergoing development within the thymus and quantitate their output from the thymus into the peripheral circulation when the expression of individual defined genes are defective. The identification of new molecules controlling regulatory T cells development and function may ultimately inform future approaches to therapeutically manipulate regulatory T cell and therefore modulate immune system activity in health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the Lymphotoxin signaling axis in the regulation of thymic microenvironments: Implications for age-associated thymic atrophy.
  • 批准号:
    BB/M006522/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $59.1万
  • 财政年份:
    2015
  • 负责人:
    William Jenkinson
  • 依托单位:
Cortical Thymic Epithelium: Defining Developmental Pathways and Specialization for Positive Selection
  • 批准号:
    G1001055/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $61.36万
  • 财政年份:
    2011
  • 负责人:
    William Jenkinson
  • 依托单位:
海外基金